Lennart C. Karssen

Lennart C. Karssen

Auto-generated profile, based on publicly available information

Lennart C. Karssen

Polyomica, ‘s-Hertogenbosch, the Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CCCARDIoGRAM consortium
CARDIoGRAM consortium
VCVeryan Codd
Veryan Codd
CNChristopher Nelson
Christopher Nelson
EAEva Albrecht
Eva Albrecht
MMMassimo Mangino
Massimo Mangino
NSNilesh J Samani
Nilesh J Samani

31 May 2017 in Diabetes
Verified
Journal Article
Open access
PDF file
RSRobert A. Scott
Robert A. Scott
LSLaura J. Scott
Laura J. Scott
RMReedik Mägi
Reedik Mägi
LMLetizia Marullo
Letizia Marullo
KGKyle J. Gaulton
Kyle J. Gaulton
IPInga Prokopenko
Inga Prokopenko
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci (P < 5 × 10−8), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants. Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes. Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action–associated loci. These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology.

10 February 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VVVirginie J M Verhoeven
Virginie J M Verhoeven
PHPirro G Hysi
Pirro G Hysi
RWRobert Wojciechowski
Robert Wojciechowski
QFQiao Fan
Qiao Fan
JGJeremy Guggenheim
Jeremy Guggenheim
CHChristopher J Hammond
Christopher J Hammond

9 November 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TCthe DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
KGKyle J Gaulton
Kyle J Gaulton
TFTeresa Ferreira
Teresa Ferreira
YLYeji Lee
Yeji Lee
ARAnne Raimondo
Anne Raimondo
AMAndrew P Morris
Andrew P Morris
Kyle Gaulton, Mark McCarthy, Andrew Morris and colleagues report fine mapping and genomic annotation of 39 established type 2 diabetes susceptibility loci. They find that the set of potential causal variants is enriched for overlap with FOXA2 binding sites in human islet and liver cells, and they show that a likely causal variant near MTNR1B increases FOXA2-bound enhancer activity, providing a molecular mechanism to explain the effect of this locus on disease risk. We performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry. We identified 49 distinct association signals at these loci, including five mapping in or near KCNQ1. 'Credible sets' of the variants most likely to drive each distinct signal mapped predominantly to noncoding sequence, implying that association with T2D is mediated through gene regulation. Credible set variants were enriched for overlap with FOXA2 chromatin immunoprecipitation binding sites in human islet and liver cells, including at MTNR1B, where fine mapping implicated rs10830963 as driving T2D association. We confirmed that the T2D risk allele for this SNP increases FOXA2-bound enhancer activity in islet- and liver-derived cells. We observed allele-specific differences in NEUROD1 binding in islet-derived cells, consistent with evidence that the T2D risk allele increases islet MTNR1B expression. Our study demonstrates how integration of genetic and genomic information can define molecular mechanisms through which variants underlying association signals exert their effects on disease.

11 May 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ECENGAGE Consortium
ENGAGE Consortium
ISIda Surakka
Ida Surakka
MHMomoko Horikoshi
Momoko Horikoshi
RMReedik Mägi
Reedik Mägi
ASAntti-Pekka Sarin
Antti-Pekka Sarin
SRSamuli Ripatti
Samuli Ripatti
Samuli Ripatti and colleagues report the results of a genome-wide association study for circulating lipid levels based on 1000 Genomes Project imputation. Their results implicate several new loci, refine the association signals at many established loci and highlight the impact of low-frequency variants on lipid traits. Using a genome-wide screen of 9.6 million genetic variants achieved through 1000 Genomes Project imputation in 62,166 samples, we identify association to lipid traits in 93 loci, including 79 previously identified loci with new lead SNPs and 10 new loci, 15 loci with a low-frequency lead SNP and 10 loci with a missense lead SNP, and 2 loci with an accumulation of rare variants. In six loci, SNPs with established function in lipid genetics (CELSR2, GCKR, LIPC and APOE) or candidate missense mutations with predicted damaging function (CD300LG and TM6SF2) explained the locus associations. The low-frequency variants increased the proportion of variance explained, particularly for low-density lipoprotein cholesterol and total cholesterol. Altogether, our results highlight the impact of low-frequency variants in complex traits and show that imputation offers a cost-effective alternative to resequencing.

29 May 2013 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
DBDorret Irene Boomsma
Dorret Irene Boomsma
CWCisca Wijmenga
Cisca Wijmenga
ESEline P Slagboom
Eline P Slagboom
MSMorris A Swertz
Morris A Swertz
LKLennart C Karssen
Lennart C Karssen
CDCornelia Van Duijn
Cornelia Van Duijn
Within the Netherlands a national network of biobanks has been established (Biobanking and Biomolecular Research Infrastructure-Netherlands (BBMRI-NL)) as a national node of the European BBMRI. One of the aims of BBMRI-NL is to enrich biobanks with different types of molecular and phenotype data. Here, we describe the Genome of the Netherlands (GoNL), one of the projects within BBMRI-NL. GoNL is a whole-genome-sequencing project in a representative sample consisting of 250 trio-families from all provinces in the Netherlands, which aims to characterize DNA sequence variation in the Dutch population. The parent–offspring trios include adult individuals ranging in age from 19 to 87 years (mean=53 years; SD=16 years) from birth cohorts 1910–1994. Sequencing was done on blood-derived DNA from uncultured cells and accomplished coverage was 14–15x. The family-based design represents a unique resource to assess the frequency of regional variants, accurately reconstruct haplotypes by family-based phasing, characterize short indels and complex structural variants, and establish the rate of de novo mutational events. GoNL will also serve as a reference panel for imputation in the available genome-wide association studies in Dutch and other cohorts to refine association signals and uncover population-specific variants. GoNL will create a catalog of human genetic variation in this sample that is uniquely characterized with respect to micro-geographic location and a wide range of phenotypes. The resource will be made available to the research and medical community to guide the interpretation of sequencing projects. The present paper summarizes the global characteristics of the project.